Ectopic Keratinization (Plantar Keratoderma)

Overview

Ectopic keratinization of the foot, most commonly called plantar keratoderma, is a group of disorders characterized by thickening (hyperkeratosis) of the skin on the soles of the feet. The term “ectopic” refers to keratin production occurring in an area where it is not normally abundant. While most cases are inherited, acquired forms may develop secondary to systemic disease, infection, or chronic irritation.

Both sexes are affected, but patterns differ by subtype. For example, the autosomal‑dominant form known as “Vörner-type” palmoplantar keratoderma affects males and females equally, whereas some X‑linked variants are primarily seen in males.

Exact prevalence is difficult to determine because many mild cases never seek care. Estimates suggest that hereditary palmoplantar keratodermas (which include plantar keratoderma) affect roughly 1 in 100,000–200,000 people worldwide [1]. Acquired forms are more common in older adults with diabetes, psoriasis, or chronic infections.

Symptoms

The presentation can vary widely, ranging from subtle roughness to painful, plaque‑like lesions. Common symptoms include:

• Thickened skin (hyperkeratosis) on the plantar surface, often symmetric.
• Yellow‑white or brown plaques that may coalesce into larger warty‑appearing areas.
• Scaling or peeling especially after prolonged walking or sweating.
• Fissuring or cracks that can bleed and become painful.
• Palpable hardness – the skin may feel stone‑like under pressure.
• Pruritus (itching) – especially after exposure to moisture.
• Burning or aching pain during weight‑bearing activities.
• Reduced ability to walk or run due to discomfort.
• Secondary infection – bacterial or fungal overgrowth in fissures.
• Associated nail changes (in some hereditary forms) such as thickened or dystrophic toenails.

In hereditary subtypes, symptoms often appear in childhood or early adolescence, whereas acquired keratoderma typically manifests after the age of 40.

Causes and Risk Factors

Inherited (Genetic) Forms

More than 20 genes have been linked to hereditary palmoplantar keratoderma. The most common mechanisms involve mutations that affect keratin filament assembly (e.g., KRT9, KRT1, KRT16) or proteins that regulate epidermal differentiation (e.g., SLURP1, PLEC). These mutations lead to abnormal accumulation of keratin, causing the skin to thicken.

Acquired (Secondary) Forms

• Systemic diseases – e.g., diabetes mellitus, hypothyroidism, ichthyosis, lupus erythematosus.
• Dermatologic conditions – psoriasis, eczema, lichen planus.
• Infections – chronic fungal (tinea pedis) or bacterial infections.
• Medications – oral retinoids, B‑complex vitamins, certain chemotherapeutic agents.
• Mechanical stress – prolonged standing, ill‑fitting shoes, occupations involving repetitive foot trauma.
• Environmental factors – chronic exposure to moisture, heat, or irritants.

Risk Factors

• Family history of keratoderma or related skin disorders.
• Presence of metabolic disease (especially uncontrolled diabetes).
• Occupations requiring long periods of standing or walking on hard surfaces.
• History of recurrent tinea pedis or other chronic foot infections.
• Use of systemic retinoids or other keratin‑modifying drugs.

Diagnosis

Diagnosing ectopic keratinization involves a combination of clinical evaluation, family history, and targeted testing.

Clinical Examination

• Visual inspection of the soles for hyperkeratotic plaques, color changes, and fissuring.
• Palpation to assess hardness and delineate borders.
• Dermatologic assessment of associated skin, nail, and mucosal findings.

Diagnostic Tools

1. Skin biopsy – Histopathology typically shows thickened stratum corneum, hypergranulosis, and acanthosis. Special stains can rule out fungal infection.
2. Genetic testing – Targeted gene panels or whole‑exome sequencing can identify pathogenic variants in known keratoderma genes. This is especially useful for hereditary cases and for genetic counseling.
3. Laboratory studies – When an acquired cause is suspected, blood tests may include fasting glucose (diabetes screening), thyroid panel, ANA (autoimmune screen), and lipid profile.
4. Fungal culture or KOH prep – To exclude tinea pedis, a common superinfection.

Differential Diagnosis

Conditions that can mimic plantar keratoderma include:

• Plantar warts (HPV infection)
• Calluses from mechanical pressure
• Erythrokeratodermia variabilis
• Psoriatic plaque on soles
• Syphilitic palmar‑plantar rash (secondary syphilis)

Treatment Options

Treatment aims to reduce hyperkeratosis, relieve pain, prevent infection, and improve function. Therapy is individualized based on severity, underlying cause, and patient preference.

Topical Therapies

• Keratolytics – 5‑10% salicylic acid or 12% lactic acid creams soften the thickened stratum corneum. Apply nightly, covering with a occlusive dressing.
• Urea creams (10–40%) – Draw moisture into the skin, softening plaques.
• Topical retinoids (tazarotene 0.05% or adapalene 0.1%) – Regulate keratinocyte differentiation; use cautiously as they may cause irritation.
• Topical steroids – Low‑to‑moderate potency (e.g., triamcinolone 0.1%) for associated inflammation or secondary eczema.

Systemic Medications

• Oral retinoids (acitretin, isotretinoin) – First‑line for severe hereditary keratoderma; dose 0.5–1 mg/kg/day. Monitor liver function, lipid profile, and teratogenicity.
• Low‑dose methotrexate – Helpful in cases linked to psoriasis.
• Biologics (e.g., secukinumab, ixekizumab) – Emerging evidence for refractory psoriatic plantar keratoderma.

Procedural Options

• Mechanical debridement – Professional podiatric filing or dermabrasion removes excess keratin. Must be performed under aseptic conditions.
• Laser therapy – CO₂ or Er:YAG lasers precisely vaporize hyperkeratotic tissue with minimal downtime.
• Photodynamic therapy (PDT) – Uses photosensitizing agents plus light to reduce thickened plaques, mainly in refractory cases.
• Surgical excision – Rarely needed; reserved for focal, nodular lesions causing functional impairment.

Lifestyle & Supportive Measures

• Moisturize twice daily with thick, petrolatum‑based ointments.
• Wear soft, breathable, well‑fitted shoes and moisture‑wicking socks.
• Use silicone or gel heel pads to reduce pressure.
• Regular foot soaking (15 min in warm water with Epsom salts) followed by gentle exfoliation.
• Maintain optimal glycemic control if diabetic.

Living with Ectopic Keratinization (Plantar Keratoderma)

Managing this chronic condition involves daily habits and occasional professional care.

Daily Foot Care Routine

1. Morning – Wash feet with mild, fragrance‑free cleanser, pat dry, then apply a urea‑based moisturizer.
2. Mid‑day – If feet become sweaty, change to dry socks and re‑apply a thin layer of antiperspirant (aluminum‑chloride) on the soles.
3. Evening – Soak feet in warm water (10‑15 min) with a tablespoon of baking soda, gently file with a pumice stone, rinse, and re‑moisturize.

Footwear Tips

• Choose shoes with a wide toe box and soft interior lining.
• Rotate shoes every 2–3 days to allow air drying.
• Consider custom orthotics that redistribute pressure away from painful plaques.

Activity Modifications

Low‑impact activities such as swimming, cycling, or elliptical training reduce mechanical stress on the soles while maintaining cardiovascular fitness.

Psychosocial Support

Visible foot lesions may affect self‑esteem. Referral to a dermatologist‑trained psychologist or support groups (e.g., Rare Diseases Clinical Research Network) can be beneficial.

Prevention

While genetic forms cannot be prevented, several strategies lower the risk of worsening or acquiring secondary keratoderma:

• Maintain healthy body weight to reduce plantar pressure.
• Control chronic illnesses (diabetes, thyroid disease) with regular medical follow‑up.
• Practice good foot hygiene—dry thoroughly after bathing.
• Avoid prolonged exposure to damp environments; change wet socks immediately.
• Use protective padding when standing for long periods (e.g., kitchen, retail).
• Screen family members for hereditary keratoderma if a pathogenic gene is known; provide genetic counseling.

Complications

If left untreated, ectopic keratinization may lead to:

• Recurrent cellulitis or abscesses due to fissure‑related bacterial entry.
• Secondary fungal infection (candidiasis, tinea pedis) that further thickens the skin.
• Painful gait abnormalities increasing risk of falls, especially in older adults.
• Charcot joint in diabetic patients—progressive foot deformity caused by neuropathic damage.
• Psychological distress from chronic pain or cosmetic concerns.

When to Seek Emergency Care

---

Sources:

1. G. B. Baran, “Genetic and acquired palmoplantar keratoderma,” Clin Dermatol, 2020. PMCID: PMC4976618
2. Mayo Clinic Staff. “Hyperkeratosis (thickened skin).” Mayo Clinic, 2023. mayo.org
3. National Institute of Arthritis and Musculoskeletal and Skin Diseases. “Palmoplantar Keratoderma.” NIH, 2022. niams.nih.gov
4. World Health Organization. “Guidelines for the Management of Skin Conditions.” WHO, 2021.
5. Cleveland Clinic. “Foot Care for Diabetes.” 2024. clevelandclinic.org